Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Opendoor Technologies Inc (OPEN) Price & Performance

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Opendoor (OPEN) trades at $1.99, down 4.78% on the day, reflecting persistent bearish sentiment amid a challenging housing market. The stock shows oversold technical signals with an RSI near 21, while fundamentals reveal steep losses with a net income margin of -46.74% in 2025 and negative ROE of -196.89%. Recent news highlights expansion into mortgages across 35-40 states by end-2026 to drive growth, but earnings misses in Q1 and Q2 2026 underscore execution risks. Cash flow improved in 2025 with net positive $538M, yet 2026 projections show renewed outflows.

The outlook remains cautious; analyst consensus is mixed with 65% hold ratings, but a $4.92 price target implies significant upside if turnaround succeeds. Key risks include interest rate sensitivity, high debt levels, and prolonged profitability challenges. Revenue declines from $15.6B in 2022 to $4.4B in 2025 highlight operational headwinds, making recovery dependent on housing market stabilization and cost controls.